Mark F. Vickers, PhD, is a Partner, registered patent agent, and member of BLG's Intellectual Property Group & National Biotech and Pharmaceutical Group.
Mark acts for innovative and groundbreaking start-ups, Universities, Research Institutions, entrepreneurs, and multinational corporations, providing strategic advice on IP acquisition and portfolio development.
Mark's practice includes the preparation and prosecution of patent applications, plant breeders' rights applications, and industrial design applications.
Mark counsels clients on technologies relating to biotechnology, agriculture, and chemistry, in various sectors, including human and veterinary therapeutics and diagnostics, agricultural sciences, small molecules, pharmaceuticals, oil and gas, and alternative energy.
Based in Ottawa, Mark works with members of BLG's intellectual property, corporate law, financial services, regulatory, and IP litigation groups, across the country, to assemble a BLG Team to provide business critical advice.
Mark has been recognized in the 2017, 2016, 2015, and 2014 editions of IAM Patent 1000 – The World's Leading Patent Practitioners.
Mark carried out doctoral and postdoctoral research in biochemistry and oncology, and gained experience in anti-cancer vaccine development at a Canadian biotechnology company.